aDepartment of Psychiatry and Psychotherapy, Technical University of Munich bDepartment of Psychology, Ludwig Maximilians University Munich, Munich, Germany.
Int Clin Psychopharmacol. 2014 Jul;29(4):224-8. doi: 10.1097/YIC.0000000000000021.
Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists' detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.
药物治疗在治疗边缘型人格障碍(BPD)患者方面似乎仍起着主要作用。然而,对于精神科医生对药物治疗的适应症和意义的详细看法却知之甚少。通过问卷调查,慕尼黑市和上巴伐利亚地区的 233 名精神科医生被问及他们在 BPD 患者的药物治疗中的治疗习惯。有 141 名精神科医生回答了问卷(60.5%)。共有 94%的 BPD 患者接受了精神药物治疗。精神科医生主要认为有必要开抗抑郁药(98%),其次是抗精神病药、情绪稳定剂和苯二氮䓬类药物。西酞普兰/艾司西酞普兰和喹硫平被提及的频率最高。这些结果与治疗 BPD 的国际指南一起进行了讨论。